Thursday, October 08, 2020 3:15:31 PM
We do know the company did at least sell a couple of new PET systems when they issued press releases indicating new system sales in 2018.
As I understand it, the market availability of the RUBY-FILL Rubidium-82 generator, did help increase the use of cardiac PET for myocardial perfusion imaging (MPI) for elderly and obese patients. Rubidium-82 has a short half life and can only be used for completing MPI at rest, and under pharmacologically induced stress. Pharmocologically induced stress is only preffered for obese or immobile that aren't capable of walking on the treadmill to create more natural exercise induced stress.
https://www.globenewswire.com/news-release/2019/12/11/1959574/0/en/Jubilant-Receives-Favorable-Ruling-from-the-U-S-Courts-for-RUBY-FILL.html
I think the availability of longer half life, Fluorpiridaz F-18, will be the tipping point where cardiac PET will be preferred over SPECT for all patient populations, and the economics will also then become favorable for small and medium sized cardiology offices to replace their SPECT equipment with cardiac PET machines.....and the Positron Attrius PET is currently the only one that doesn't also include expensive to operate and maintain CT system as well....which isn't needed for PET MPI:
https://www.mobilecardiacpet.com/pet-mpi-statistics/
I bought near the lows in 2018 and have been continuing to accumulate
into the teens because I believe the company is well positioned to benefit from this coming seachange in cardiac imaging modalities.....and I think there's a good chance of this stock being worth dollars when the market sees the opportunity coming their way as well.
"Our houses are such unwieldy property that we are often imprisoned rather than housed in them." - Henry David Thoreau, Walden: Economy, 1854
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM